What Is Tardive Dyskinesia?
Tardive dyskinesia (TD) is a disorder that results in involuntary, repetitive body movements. This may include grimacing, sticking out the tongue, or smacking the lips. Additionally there may be rapid jerking movements or slow writhing movements. In about 20% of people, decreased functioning results. Tardive dyskinesia occurs in some people as a result of long-term use of neuroleptic medications (antipsychotics, metoclopramide). These medications are usually used for mental illness, but may also be given for gastrointestinal or neurological problems. The condition typically develops only after months to years of use. The diagnosis is based on the symptoms after ruling out other potential causes.
Common Signs and Symptoms of TD:
Pursing of the lips
Excessive eye blinking
Tardive Dyskinesia Study Treatments
Insight Clinical Trials has the opportunity to further evaluate an existing, approved medication treatment for TD. But this cannot be done without research volunteers. TD study treatment is dependent upon your current symptoms and treatment regimens. For specific details of study treatments, please contact us using this web form or give us a call to schedule an appointment.
How can we help?
If you have Tardive Dyskinesia you are not alone.
Your first visit to Insight Clinical Trials will consist of a free mental health evaluation.
All of the assessments done throughout the study are free of cost and study medication is also provided at no cost. Insurance is not needed or required. If you are interested in learning more about our TD studies then complete the web form below or give us a call to schedule an appointment.
We currently have several different opportunities for research treatments.
We are looking for study candidates that are treatment naive (have not had treatment before for TD)
We are seeking those that have previously taken TD medication before, but are not currently, or who are willing to discontinue their current treatment
No Cost Study
There is no cost to participate in the study, and the study participant who is eligible will receive the following:
Study Related Medical Care
Compensation up to $1050.00
For more information about participating in this clinical trial, call us at (216) 526-1843 or click the button below.